| Hint | Answer | % Correct |
|---|---|---|
| Selective serotonin reuptake inhibitor (SSRI), used for depression | Escitalopram | 84%
|
| Angiotensin converting enzyme (ACE) inhibitor, used for hypertension | Enalapril | 63%
|
| Proton pump inhibitor (PPI), used for GERD and peptic ulcer disease | Esomeprazole | 63%
|
| SGLT2 inhibitor, used for diabetes mellitus and heart failure | Empagliflozin | 58%
|
| Cholesterol-lowering medication that blocks cholesterol reabsorption in the small intestine | Ezetimibe | 47%
|
| Mineralocorticoid receptor antagonist (MRA), used for heart failure | Eplerenone | 42%
|
| Medication used to treat migraines, derived from ergot fungi | Ergotamine | 37%
|
| Selective beta blocker, lowering heart rate | Esmolol | 37%
|
| Antibiotic given for tuberculosis, part of the RIPE regimen | Ethambutol | 37%
|
| Anti-HIV medication of the non-nucleoside reverse-transcriptase inhibitor (NNRTI) class | Efavirenz | 32%
|
| Anti-HIV medication of the nucleoside reverse-transcriptase inhibitor (NRTI) class | Emtricitabine | 32%
|
| Antibiotic of the carbapenem (β-lactam) class | Ertapenem | 32%
|
| TNF inhibitor, but not a monoclonal antibody | Etanercept | 26%
|
| Anti-seizure medication, specifically used for absence seizures | Ethosuximide | 26%
|
| Monoclonal antibody against PCSK9; alternative to statins for hypercholesterolemia | Evolocumab | 16%
|
| The first GLP-1R agonist discovered; isolated from the saliva of the Gila monster | Exenatide | 16%
|
| Monoclonal antibody targeting complement, used for paroxysmal nocturnal hemoglobinuria | Eculizumab | 11%
|
| Anti-HIV medication that prevents fusion of the virus with the host cell | Enfuvirtide | 11%
|
| Inhibitor of EGFR, used for lung cancer and pancreatic cancer | Erlotinib | 11%
|
| Immunosuppressive mTOR inhibitor; being studied for aging | Everolimus | 11%
|